Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Zyrwan OD 20mg*


Contraindicated
Extrapyramidal symptoms and / or withdrawal symptoms in neonates exposed during the 3rd trimester of pregnancy

Contraindicated
Zyrwan OD 20mg* :
Type Medicine Non Marketed
Originator G
Agent Raymond Georges Abou Adal
Distributor Raymond Georges Abou Adal
Laboratory Arwan Laboratories
Manufacturer Adamed Pharma sa
Manufacturing Type Adamed Pharma S.A. Ksawerow, Poland for Arwan Pharmaceutical Industries Lebanon SAL
Origin Poland
ATC N05AH03

Your comment will appear shortly after approval

Zyrwan OD 20mg* :

Revision Date : 13/04/2015


Effect Frequency
Abdominal distension Uncommon
Akathisia Common
Alopecia Uncommon
ALT increased Very Common
Amenorrhoea (amenorrhea) Uncommon
Amnesia Uncommon
Anticholinergic syndrome Common
Arthralgia (Pain joint) (Joint ache) Common
AST increased Very Common
Asthenia Common
Bilirubin total increased Uncommon
Blood alkaline phosphatase increased Common
Blood bilirubin decreased Very Common
Blood cholesterol increased Common
Blood creatine phosphokinase increased Common
Blood glucose increased Common
Blood prolactin increased Very Common
Blood triglycerides increased Common
Body temperature increased Common
Bradycardia Uncommon
Breast enlargement Uncommon
Cerebrovascular accident Not known
Cholestatic liver injury Rare
Coma Uncommon
Constipation Common
Death Not known
Deep vein thrombosis Uncommon
Diabetes mellitus Uncommon
Dizziness Common
Dry mouth (Xerostomia) Common
Dysarthria Uncommon
Dyskinesia Common
Dystonia Uncommon
ECG QT prolonged Uncommon
Eosinophilia Common
Epistaxis (Nasal bleeding) Uncommon
Erectile dysfunction Common
Erythema Common
Fall Very Common
Fatigue Common
Gait abnormal Very Common
Galactorrhoea Uncommon
Gamma-GT increased Very Common
Glucosuria (Glycosuria) Common
Gynecomastia (Gynaecomastia) Uncommon
Hallucination Very Common
Hallucination, visual Common
Hepatitis Rare
Hepatocellular injury Rare
Hypersensitivity Uncommon
Hypersomnia Very Common
Hypothermia Rare
Increased appetite Common
Ketoacidosis Uncommon
Lethargy Very Common
Leucopenia (Leukopenia) Common
Libido decreased Common
Mixed liver injury Rare
Neuroleptic malignant syndrome Rare
Neutropenia Common
Oculogyration Uncommon
Oedema Common
Orthostatic hypotension Very Common
Pancreatitis Rare
Parkinsonism Common
Parkinsonism aggravated Very Common
Photosensitivity reaction Uncommon
Pneumonia Common
Priapism Rare
Pulmonary embolism Uncommon
Pyrexia Common
Rhabdomyolysis Rare
Sedation Very Common
Seizures Uncommon
Skin rash Common
Somnolence Very Common
Speech disorder Common
Sudden death Rare
Tardive dyskinesia Uncommon
Thrombocytopenia (Thrombopenia) Rare
Thromboembolism Uncommon
Tremor aggravated Not known
Uric acid high Common
Urinary hesitation Uncommon
Urinary incontinence Common
Urinary retention Uncommon
Ventricular fibrillation Rare
Ventricular tachycardia Rare
Weight increased (weight gain) Very Common
Withdrawal syndrome Rare
Withdrawal syndrome neonatal Not known

Different Units By MoH Code

Revision Date : no date

Zyrwan OD 20mg*  MoH 6937 :
Form Tablet, Orodispersible
Packaging Blisters
Package Size Box of 14
Strength 20mg
Storage Condition <25°C protect from light
NSSF ✘
Quarantine ✘
Reg. Number 97462/12
Submission date 01/01/2012
Registration Year 2013
Archived Date 02/03/2021


Price Comparison

● Country: Kuweit
● Package Size: Boîte de 14
● Public Price: 17.6 KWD ( 5,167,025.60 LBP )
● Pack size unit used: 14
● Cost/Unit: 1,2571 KWD ( 293,581.00 LBP )
● Pharmacy Price: 14.87 KWD ( 4365549.47 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info